MARKET

AZN

AZN

AstraZeneca
NYSE

Real-time Quotes | Nasdaq Last Sale

47.61
+0.60
+1.28%
Pre Market: 48.50 +0.89 +1.87% 08:59 11/22 EST
OPEN
46.77
PREV CLOSE
47.01
HIGH
47.87
LOW
46.67
VOLUME
91.19K
TURNOVER
--
52 WEEK HIGH
49.22
52 WEEK LOW
35.30
MARKET CAP
124.91B
P/E (TTM)
59.11
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of AZN and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

AZN News

  • SVB Leerink Initiates Coverage On AstraZeneca with Outperform Rating
  • Benzinga.1m ago
  • Here are the biggest analyst calls of the day: Uber, Alibaba, Zoom & more
  • CNBC.com.20m ago
  • Stocks making the biggest moves premarket: Foot Locker, Nordstrom, Gap, Zoom Video & more
  • CNBC.com.40m ago
  • CALQUENCE Approved in the US for Adult Patients With Chronic Lymphocytic Leukemia
  • Business Wire.18h ago

More

Industry

Pharmaceuticals
+0.60%
Pharmaceuticals & Medical Research
+0.42%

Hot Stocks

Name
Price
%Change

About AZN

AstraZeneca PLC (AstraZeneca) is a biopharmaceutical company. The Company focuses on discovery and development of products, which are then manufactured, marketed and sold. The Company focuses on three main therapy areas: Oncology, Cardiovascular & Metabolic Disease (CVMD) and Respiratory, while selectively pursuing therapies in Autoimmunity, Infection and Neuroscience. In CVMD, it is expanding its portfolio into the cardiovascular-renal area with late-stage assets, such as ZS-9 and roxadustat, as well as investing to explore the benefits of its SGLT2 and GLP-1 franchises in chronic kidney disease (CKD) and heart failure (HF). The Company has approximately 40 projects in Phase I, including 29 new molecular entities (NMEs), and 11 oncology combination projects. It has approximately 40 projects in Phase II, including 25 NMEs; four significant additional indications for projects that have reached phase II, and seven oncology combination projects.
More

Webull offers AstraZeneca plc (ADR) (AZN) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.